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Abstract
Background: Glycogen-depleting exercise can lead to supercompensation of muscle glycogen stores, but the biochemical
mechanisms of this phenomenon are still not completely understood.
Methods: Using chronic low-frequency stimulation (CLFS) as an exercise model, the tibialis anterior muscle of rabbits was
stimulated for either 1 or 24 hours, inducing a reduction in glycogen of 90% and 50% respectively. Glycogen recovery was
subsequently monitored during 24 hours of rest.
Results: In muscles stimulated for 1 hour, glycogen recovered basal levels during the rest period. However, in those
stimulated for 24 hours, glycogen was supercompensated and its levels remained 50% higher than basal levels after 6 hours
of rest, although the newly synthesized glycogen had fewer branches. This increase in glycogen correlated with an increase
in hexokinase-2 expression and activity, a reduction in the glycogen phosphorylase activity ratio and an increase in the
glycogen synthase activity ratio, due to dephosphorylation of site 3a, even in the presence of elevated glycogen stores.
During supercompensation there was also an increase in 59-AMP-activated protein kinase phosphorylation, correlating with
a stable reduction in ATP and total purine nucleotide levels.
Conclusions: Glycogen supercompensation requires a coordinated chain of events at two levels in the context of decreased
cell energy balance: First, an increase in the glucose phosphorylation capacity of the muscle and secondly, control of the
enzymes directly involved in the synthesis and degradation of the glycogen molecule. However, supercompensated
glycogen has fewer branches.
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Introduction
Glycogen, the branched polymer of glucose, is the main energy
reserve in muscle and is also important for glucose homeostasis.
Muscle glycogen levels are regulated by glycogenin, muscle
glycogen synthase (mGS) and glycogen phosphorylase (mGPh).
mGS is the key enzyme for glycogen synthesis. Regulation of its
activity includes allosteric regulation by the activator glucose-6P
and phosphorylation at nine different sites, which in general
inactivates the enzyme [1]. Phosphorylation of sites 2 (Ser7 in the
rabbit enzyme) and 2a (Ser10) in the N-terminus and sites 3a
(Ser640) and 3b (Ser644) in the C-terminus has the greatest
influence on its activity [2]. The phosphorylation state of the
remaining sites (1a, 1b, 3c, 4 and 5) has little or no effect on
enzyme activity in vitro.
Muscle glucose uptake and phosphorylation also control
glycogen synthesis through substrate availability [3–5]. Glucose
is phosphorylated by hexokinase. The vast majority of hexokinase
activity in muscle is delivered by the hexokinase 2 isoform [6]. The
59-AMP-activated protein kinase (AMPK) acts as a sensor of
cellular energy charge [7]. It is activated by phosphorylation under
conditions of energetic stress, such as muscle contraction. The
enhanced activity of AMPK during contraction leads to increased
muscle contraction-dependent glucose transport via an increase in
GLUT4 recruitment to the cell membrane [3]. Clearly AMPK
play a central role in muscle adaptation to contraction [8] and
regulating glycogen synthesis through acute effects such as glucose
availability and chronic effects involving the control of gene
expression [9].
An increase in muscle glycogen content above basal levels is a
well-established phenomenon known as supercompensation. It is
widely used as a strategy by athletes to enhance performance in
endurance events, as it helps to postpone fatigue [10]. It has been
shown [11] that a high carbohydrate diet following glycogen-
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depleting exercise leads to supercompensation of muscle glycogen
stores, which remain stable above basal levels for up to several
days. Supercompensation can be achieved in other situations such
as refeeding after starvation [12], chronic low-frequency stimula-
tion [13], or in cultured muscle cells subjected to hypoxia [14].
Despite significant efforts to study this phenomenon, its mecha-
nisms are still not fully understood. Various studies have suggested
multiple mechanisms for glycogen supercompensation, such as
altered glucose transport [15], increased availability of glycogenin
[16], or reduced glycogen degradation by mGPh [13].
A better understanding of glycogen resynthesis and the
mechanism(s) that lead(s) to supercompensation after muscle
contraction is important not only to improve exercise performance
in athletes, but also to understand the regulation of muscle
glycogen metabolism and the role it plays in diseases such as type 2
diabetes. Using chronic low-frequency stimulation (CLFS) of
rabbit muscle as an exercise model [17], a number of biochemical
parameters related to glycogen metabolism and supercompensa-
tion were analyzed.
We report that the supercompensation mechanism is dependent
on the overexpression of hexokinase 2 and coordinated changes in
mGS, mGPh and AMPK activity. Together, these adaptations
lead to a transient increase in muscle glycogen stores, composed of
less frequently branched, enlarged molecules.
Materials and Methods
Chemicals and reagents
UDP-[U-14C]-glucose for use in glycogen synthase (GS) and
glycogenin activity assays was synthesized as described previously
[18]. Secondary antibodies coupled with horseradish peroxidase
were purchased from Dakocytomation (Glostrup, Denmark). All
other reagents were of analytical grade and were purchased from
Sigma-Aldrich (Madrid, Spain) or Amersham Pharmacia Biotech
(Munich, Germany), unless otherwise specified.
Experimental model
All experiments were approved by the University of Barcelona
Ethics Committee and complied with the APS’s Guiding
Principles in the Care and Use of the Animals. All surgical
procedures were done under ketamine anesthesia and during the
post-surgery recovery buprenorphine was administered to the
animals. All efforts were done to minimize suffering. Adult female
white New Zealand rabbits weighing between 3.0 and 3.5 kg were
housed in temperature- and humidity-controlled conditions, with a
12 hour light/12 hour dark cycle. They were allowed food and
water ad libitum. Comparable food consumption in all animals in
different treatment groups was confirmed by weighing the food
they had eaten. The composition of the diet (Teklad global 2030,
Harlan, Indianapolis, IN) was 56.7% carbohydrate, 16.9% protein
and 3% fat. Following the method described by Pette et al. [19],
stimulating electrodes were implanted on both sides of the
peroneal nerve, which innervates the fast-twitch tibialis anterior
muscle of the left leg. Two electrostimulation protocols (10 Hz,
18 mA of amplitude and impulse width of 0.15 ms) were applied
(Figure 1): 1 hour stimulation (1A), or 24 hours stimulation (1B).
After stimulation, animals were allowed to recover for 0 (no rest),
1, 6, 12 or 24 hours. Following this recovery period, tibialis anterior
muscles were taken and immediately frozen in liquid nitrogen and
stored at 280uC until further analysis. To minimize circadian
variability, all samples were collected between 12 pm and 2 pm by
planning the start of the stimulation period accordingly. Five
animals were sampled per group, collecting both the stimulated
muscle (left leg) and the contralateral non-stimulated control (right
leg), with n = 50 control samples in total. The insulin level in the
serum was measured by radioimmunoassay (Insulin-CT kit, CIS
Bio International). The glucose level in the serum was measured
using a glucometer (Lifescan OneTouch Ultra).
Metabolite measurement
Glycogen was extracted by digesting the tissue with 30% KOH,
followed by three 66% ethanol precipitations as described
previously [20]. The precipitate was digested and the glucose
assayed as described by Prats et al. [17]. Krisman’s method was
used to assess glycogen branching [21]. In brief, extracted
glycogen was mixed with a solution of saturated CaCl2 containing
6 mM KI and 0.4 mM I2. The absorbance spectrum was recorded
from 350 to 750 nm. Extraction of metabolites and nucleotides
was performed as described elsewhere [22]. ATP, creatine,
creatine-P, glucose and glucose-6P were assessed as described
previously, following the method of Lowry and Passonneau [23].
Purine nucleotide determination (ATP, ADP, AMP, Adenosine,
IMP, and NAD) was performed by reverse-phase high perfor-
mance liquid chromatography (HPLC), following the method of
Tullson et al. [24]. The AMP/ATP ratio and total purines were
calculated using the ATP data obtained via HPLC.
Enzyme activities
All enzyme activity assays were conducted at 30uC. Fractional
GS activity was measured in total extracts following the method
described by Guinovart et al. [25]. GPh activity was measured
following the method of Gilboe et al. [26]. The latter method was
also used to elongate glycogen. Briefly, the reaction contained
citrate 100 mM (pH 7.4), AMP 5 mM, purified GPh b in excess
(0.2 mg/ml), glucose-1P 50 mM and purified glycogen as the
limiting substrate (up to 10 micrograms/ml). Glycogen was
purified following the method of Tagliabracci et al. [27]. Total
Figure 1. Experimental model. The horizontal arrows show the
Chronic Low Frequency Stimulation period 1 hour (A) or 24 hours (B)
after recovering from the surgery (4 days). Then both stimulated and
non-stimulated contralateral tibialis anterior muscles were sampled at
0 hours (right after CLFS), 1, 6, 12 and 24 hours of rest. Collection of the
samples was done always at the same hour of the day for both
protocols.
doi:10.1371/journal.pone.0042453.g001
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hexokinase (HK) activity was measured as described by Davidson
et al. [28] using 0.1% Triton X-100 in the extraction buffer.
Glycogenin transglucosylase activity was measured following the
method of Cao et al. [29], with some modifications. Briefly, the
homogenate was treated with a-amylase 40 U/ml for 1 hour at
room temperature or left untreated and immediately assayed.
Five microlitres of homogenate was added to 5 ml of freshly
prepared reaction mix and assayed as described above. The
activity in each sample was taken as the difference between
activity in the amylase-treated sample and that in the untreated
sample. Glycogen branching enzyme (GBE) activity was assayed
indirectly by measuring the stimulation of incorporation of
glucose-1-P into glycogen by glycogen phosphorylase b as
described by Bruno et al. [30]. Sufficient purified glycogen was
added to the reaction to avoid artifacts due to differences in
endogenous glycogen. Protein concentration was measured using
the Bradford method [31].
Immunoblot analysis
The primary antibodies used were: muscle GS (mouse
monoclonal from Chemicon, dilution 1:2000), glycogenin (guinea
pig polyclonal, dilution 1:2000), AMPK-P (T172) (rabbit poly-
clonal from Cell Signalling, dilution 1:1000), and AMPKa1 or
AMPKa2 (goat polyclonal, dilution 1:2000). Antibodies against
GS phosphorylated at sites 1a (Ser697), site 1b (Ser710), 2, 2+2a
(Ser7 and Ser10), 3a (Ser640), 3b (Ser644), 4 and 4+5 (Ser652
and Ser656) were raised in goat, and were used at a dilution of
1 mg/ml (sites 3a, 3b, 4 and 5), 2 mg/ml (site 2+2a), 1:700 (site 2),
1:1000 (site 1b) or 1:2000 (site 1a), as previously described [32].
Immunoblots were performed as described previously [17].
Phosphorylated AMPK content was normalized by AMPKa1
total content, while phosphorylation of the different sites of mGS
was normalized by mGS total protein content. Glycogenin, total
GS, AMPKa1 and a2 content were normalized by total protein
measured in Coomassie brilliant blue stained gels (linear from 1
to 30 micrograms of protein). This method was used to avoid
artifacts due to differences in other housekeeping proteins, the
content of which may change according to the stimulation
protocol.
RNA isolation and quantitavive PCR
RNA was prepared with the TriPure Isolation ReagentH
(Roche), following the procedure suggested by the manufacturer.
The RNA was then subjected to reverse transcription using the
Superscript II-RT kit (Invitrogen) according to the manufacturer’s
instructions. The cDNA was stored at 280uC before subsequent
analysis. Primers and probes were designed for the hk2 rabbit gene,
according to the requisites of Taqman real-time PCR using the
program Primer ExpressH (Applied Biosystems):
TGCTGCCGACCTTTGTGA as the forward primer,
AAGGTCCAGAGCCAGGAACTC as the reverse primer, and
TCCACTCCAGATGGCACAGAACACG as the probe. The
probe was labeled with FAM as the dye and TAMRA as the
quencher. 18S rRNA was used as a housekeeping control gene
(assay-on-demandH hs99999901_s1, Applied Biosystems). The
Real-Time PCR protocol was performed according to the
manufacturer’s instructions (Applied Biosystems). The fold-change
in the hk2 mRNA content of stimulated samples with respect to the
contralateral non-stimulated control samples was calculated
following the method of Pfaffl [33].
Statistical Analyses
For each parameter, kurtosis and skewness were calculated to
test for a normal distribution. Normally distributed data obtained
from the stimulated muscle were compared against data obtained
from the contralateral non-stimulated control muscle using
Multiple-Way Analysis of Covariance, followed by the LSD
post-hoc test. For studies in which only a number of control
muscles were assayed, groups were compared using a Multiple-
Way Analysis of Variance, followed by the LSD post-hoc test. In
non-normally distributed datasets, the values of all groups were
compared using the non-parametric Mann-Whitney U-test and
the Kruskal-Wallis test.
Results
Glycogen content and structure
After 1 hour of CLFS there was a significant reduction in
glycogen content, reaching 10% of the basal value (Figure 2A).
Glycogen levels recovered to levels comparable to those in the
control muscle after 6 hours of rest. After 24 hours of CLFS,
glycogen decreased to 50% of the control. During the subsequent
rest period, levels reached basal values after 1 hour, and then
further increased up to 6 hours, leading to supercompensation.
Levels then remained stable for up to 24 hours of rest. We then
analysed the degree of branching by intercalating iodine in the
purified glycogen (Figure 2B). A shift in the absorption maximum
to a higher wavelength correlates with a lower degree of
branching. After 1 hour of CLFS, and coinciding with the lowest
glycogen levels, branching increased, and then decreased during
the glycogen resynthesis period, progressively returning to basal
values. After 24 hours of CLFS, glycogen branching was
significantly lower than normal. The lowest branching value was
observed during resynthesis and supercompensation. Normal
branching values were only reached after 24 hours of rest. To
test the effect of branching on the efficiency of glycogen as a
substrate, 2.4 micrograms of purified glycogen extracted from
samples under different situations were elongated using glycogen
phosphorylase and glucose-1-P in excess (Figure 2C). Incorpora-
tion of glucose into poorly branched glycogen at basal levels (24 h
CLFS +1 h rest) or supercompensated levels (24 h CLFS+6 h rest)
was reduced, but did not differ from the control in normally
branched supercompensated glycogen (24 h CLFS+24 h rest).
Blood glucose, insulin and muscle metabolite and
nucleotide levels
There was no significant modification in blood insulin during
CLFS or the rest period (Table 1). Blood glucose was slightly
increased at the beginning of the rest period in both protocols, but
subsequently returned to basal levels. Muscle glucose-6P (Table 1)
levels decreased significantly after the period of stimulation (both 1
and 24 hours), returning to basal levels once glycogen had been
resynthesized.
In order to evaluate the energy status of the muscles, the ATP
content (enzymatically and by HPLC), total purines (ATP+AD-
P+AMP+adenosine+IMP), the AMP/ATP ratio, total creatine and
creatine-P/total creatine ratio were determined (Table 1). The
results suggest that differences in ATP content were the
determining factor in changes in total purines and the AMP/
ATP ratio, so only ATP was measured in groups beyond 6 hours
of rest. The ATP content was significantly reduced after 1 hour of
CLFS but had recovered after 6 hours of rest. In contrast,
although the levels of ATP were also significantly decreased after
24 hours of CLFS, 24 hours of rest were not sufficient to recover
control values. The total creatine levels were unchanged in all
situations, while the creatine-P/total creatine ratio generally
followed a similar pattern to ATP levels.
Hexokinase and Glycogen Supercompensation
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Glucose phosphorylation
We then focused on glucose phosphorylation. After 12 hours of
rest, HK activity (Table 2) increased significantly in the 1-hour
CLFS group, preceded by an increase in hexokinase 2 mRNA
(Figure 3). The 24-hour CLFS group showed a prominent and
stable increase in HK activity throughout the resting period,
accompanied by an even greater increase in the hk2 transcript,
which returned to control values after 12 hours of rest.
Glycogen synthesis
We subsequently studied the enzymes controlling glycogen
synthesis. There was no change in glycogenin transglycosylating
activity (Table 2) or protein content (Figure 4) in any situation.
Total mGS activity, measured by the presence of high glucose-6P
(GS-H), remained unchanged (Table 2), with the exception of
immediately after 1 hour of CLFS, when a decrease of about 70%
was detected, although this was not correlated with the protein
levels measured by Western blotting. mGS protein levels did not
change significantly under any situation (Figure 5A). The L/H
activity ratio (Table 2) increased after 1 hour of CLFS, returning
to basal levels after 6 hours of rest, which coincided with the
restoration of glycogen content. After 24 hours of CLFS, the
activity ratio showed a less substantial increase, but remained high
after 1 hour of rest, even though glycogen levels had already been
restored. After 6 hours of rest, the activity ratio returned to basal
values.
The phosphorylation content of the different sites of mGS was
measured by Western blotting using phosphospecific antibodies to
the sites 1a, 1b, 2, 2+2a, 3a and 3b (Figure 5). The phosphor-
ylation of sites 1a, 1b, 2+2a, 3a and 3b was reduced during both
CLFS events and after 1 hour of rest following 1 hour of CLFS,
correlating with the reduction in glycogen content. The phos-
phorylation content of sites 1a (Figure 5B), 2+2a (Figure 5E) and
3b (Figure 5G) returned to normal values when glycogen stores
achieved basal levels. Moreover, when glycogen was super-
compensated site 2+2a was hyperphosphorylated. The phosphor-
ylation content of site 1b (Figure 5C) and 3a (Figure 5F) followed
the same pattern as sites 1a and 3b after 1 hour of CLFS.
However, after 24 hours of CLFS the phosphorylation content of
site 1b remained lower for up to 12 hours of rest and that of site 3a
for up to 1 hour of rest, even though glycogen levels had already
been restored. Both later returned to baseline levels. Site 2
(Figure 5D) phosphorylation remained unchanged in all situations.
GPh activity, measured in the presence of AMP (GPh total), was
unchanged in all situations (Table 2). The GPh activity ratio
(Table 2) decreased after 1 hour of CLFS, returning to basal levels
as glycogen content was restored. The activity ratio decreased less
drastically after 24 hours of CLFS compared to after 1 hour. It
was still low after 12 hours of rest. The activity ratio only returned
to basal values after 24 hours of rest.
Glycogen branching enzyme activity remained unchanged,
except in the 24-hour CLFS/24-hours rest group, in which we
recorded an increase in total activity of 45% over the control.
AMPK
Lastly, we analyzed AMPK. The activation state of AMPK, as
judged by phosphospecific antibodies to the activating T-loop
phosphorylation site, showed that phosphorylation greatly in-
creased after 1 hour of CLFS and, in parallel with the restoration
of glycogen levels, returned to basal values after 6 hours of rest
(Figure 6A, 6B, 6C). After 24 hours of CLFS, AMPK phosphor-
ylation increased to a lesser extent than after 1 hour of CLFS, but
the levels were only restored after 12 hours of rest, long after
glycogen levels were restored. The levels of isoform AMPKa2, the
Figure 2. Glycogen content and the absorbance branching
index. (A) Glycogen content of 1 hour (& bar) or 24 hours (& bar)
stimulated muscles (mmols of glucose/g tissue). (B) Wavelength of the
maximum absorbance peak (nm) as branching index (& dots are
1 hour CLFS samples and & dots are 24 hours CLFS samples). Control
group (% bar or dot) was composed with the pool of all contralateral
non-stimulated muscle samples results (n = 50). n = 5 for the stimulated
and rested groups. (C) The same amount (2.4 micrograms) of control
(white circles), poorly branched normal content (24 h CLFS+1 h rest,
grey triangles), poorly branched supercompensated (24 h CLFS+6 h
rest, grey diamond) and normal branched supercompensated (black
squares, 24 h CLFS+24 h rest) purified glycogen samples were
elongated using GPh-b. Glucose incorporation from G1P was monitored
at 5, 15, 30, 4 and 60 minutes. n = 3–5. Data are means 6 SE. Bars or
dots with the same letter are not significantly different from each other.
*: p,0.05 compared with control.
doi:10.1371/journal.pone.0042453.g002
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catalytic subunit of AMPK that is phosphorylated, remained
unchanged under all conditions (Figure 6E). However, the amount
of isoform a1 (Figure 6D) significantly increased after 24 hours of
rest in both protocols.
Discussion
The aim of this study was to examine the response of glycogen
metabolism to rest after the depletion of glycogen following 1 or
24 hours of CLFS. The results obtained after 1 hour of CLFS
contrast with studies in which glycogen was supercompensated
after glycogen depletion followed by a carbohydrate load
[11,34,35], possibly because the animals were fed a diet that was
moderately high in carbohydrates (56.7%) ad libitum. In contrast,
after 24 hours of CLFS, rest led to clear supercompensation of
glycogen above 50% of basal levels. Given that the eating
behaviour, blood glucose and insulin levels were the same in both
CLFS groups, we believe that the glycogen supercompensation
mechanism in this model is dependent exclusively on local muscle
effectors such as the stimulation and resynthesis conditions.
One of the major findings in this comparative study is that a
sustained and time-coordinated decrease in cellular energy charge
and increase in glucose phosphorylation activity and glycogen
synthesis are required to allow glycogen over-accumulation
independently from diet. In particular, two parameters found
upstream of other modifications are pivotal to explaining glycogen
supercompensation.
The first is a stable decrease in ATP and P-Cr levels, along with
the net loss of purine nucleotides that occurs during the rest period
in muscles stimulated for 24 hours. We believe that the net loss of
purines is an indication that the muscle had entered long-term
fatigue, preventing recovery of the cellular energy charge [36].
This also correlates with the sustained phosphorylation of AMPK
during glycogen recovery and supercompensation. In addition, we
report an increase of the content of AMPK1a subunit 24 hours
after the stimulation period, contributing to enhanced AMPK
activity, in agreement with previous studies on CLFS [8].
Activation of AMPK increases glucose uptake by translocating
Figure 3. HK2 cDNA change. Fold change in hk2 mRNA content of
1 hour (&) or 24 hours (&) stimulated samples compared to control
situation measured with Real-Time PCR. Control group (%) was
composed with the pool of all contralateral non-stimulated muscle
samples results (n = 50). n = 5 for all the other groups. Data are means6
SE. Bars with the same letter are not significantly different from each
other.
doi:10.1371/journal.pone.0042453.g003
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GLUT4 to the sarcolemma [37] and enhances fatty acid uptake
and oxidation and mitochondrial biogenesis [9], which is
consistent with the previously reported effects of long-term CLFS
[38]. In this context, glucose could be spared from glycolysis and
directed towards the synthesis of glycogen, favouring super-
compensation.
The second important upstream factor is an enhanced capacity
for glucose phosphorylation, due to increased HK activity, likely
ascribed to HK-2. In addition to the increased hk2 expression
reported here, the contribution of HK-1 to total HK activity in
muscle lies at around 6–10% [39] and previous studies have shown
that muscle contraction increases HK-2 activity and gene
expression, without changes in HK-1 [40,41]. Fueger and
Wasserman [4,5] demonstrated that glucose phosphorylation
becomes the limiting component in muscle glucose uptake during
hyperinsulinaemia or exercise. Moreover, a delayed increase in
HK in the group subjected to 1 hour of CLFS, which occurred
when glycogen synthesis had finished and other modifications had
already faded, did not lead to supercompensation, in agreement
with previous studies [42]. Taken together, these findings highlight
the crucial role of hexokinase and the need for coordination with
other events leading to glycogen supercompensation.
In contrast to the above, glycogenin content remained
unchanged during exercise and rest. Therefore, the increase in
glycogen content in this model is due to an increase in the size of
preexisting molecules, rather than an increase in their total
number, correlating with a previous study of glycogen resynthesis
[43], but arguing against a role in glycogen supercompensation, as
reported elsewhere [16].
Furthermore, supercompensation could not be explained by an
increase in the total activity of GS or a decrease in GPh. We only
observed a decrease in total GS activity immediately following
1 hour of CLFS, with no accompanying change in protein
content. This phenomenon has been reported after intense
contractile activity [44] but is still not fully understood. On the
other hand, although there was a close inverse correlation between
the phosphorylation of sites 1a, 1b, 2+2a, 3a and 3b with glycogen
content and mGS activity in all groups, as previously reported
[45–47], after 1 hour of rest, in the 24-hour CLFS group we
recorded decreased phosphorylation of sites 1b and 3a and
increased GS fractional activity despite the presence of basal
glycogen levels. To our knowledge, this is the first study to have
reported such a disconnection, which can be attributed to
regulation of site 3a phosphorylation, a site that is known to
control GS activity [2]. The participation of site 1b in this model is
not clear, since its role in GS regulation is not well understood.
However, mGS is known to be translocated to different cell
structures or compartments [17,44,47,48]. In particular, Prats et
al. [49] reported that during glycogen resynthesis, mGS is
redistributed into intramyofibrillar and intermyofibrillar compart-
ments, depending on the phosphorylation of site 1b and site 2+2a,
respectively. Thus, dephosphorylation of mGS site 1b and
hyperphosphorylation of site 2+2a suggests that mGS is involved
in the elongation of the intermyofibrillar glycogen in the super-
compensated pool. Overall, site 2 phosphorylation remained
unchanged under all experimental conditions despite increased GS
activity, in accordance with Lai et al. [46]. This might be
attributed to the balance between regulatory signals working on
this site, rather than a lack of control. One candidate is AMPK,
since it was found to be hyperphosphorylated in the present study
and has been suggested to be a mGS site 2 kinase in vivo [7].
In parallel, there was a sustained decrease in the mGPh activity
ratio after 24 hours of CLFS. This suggests a role for mGPh in
allowing glycogen turnover towards synthesis, and further
maintaining supercompensation in vivo, as reported in other
models such as ex-vivo muscles and cell culture [13,50]. Protein
phosphatase 1 may potentially control the differential regulation of
mGS and mGPh phosphorylation [51]. Further research is
required to fully understand this role.
Another important and novel outcome of this study is that newly
synthesized glycogen becomes transiently less branched, returning
to its basal structure when glycogen turnover is restored, regardless
of changes in GBE. This phenomenon is similar to that found in
various rare genetic conditions, such as Lafora disease [27].
Moreover, although glycogen is known to inhibit AMPK
phosphorylation [52,53], poorly branched polyscacharydes are
less potent inhibitors in vitro [54], further correlating with our
observations in vivo. We also demonstrated that poorly branched
glycogen is less efficient substrate for GPh, similar to the enlarged
glycogen model proposed by Melendez et al. [55]. Therefore,
differences in branching could explain the discrepancies in exercise
performance found in studies reporting improvements [56] or lack
of any effect [57] related to increased muscle glycogen content. To
maximize exercise performance, we propose adapting the timing
of pre-exercise training strategies, such that glycogen is super-
compensated during recovery, but branching is allow to revert to
normal.
In summary, our results show that glycogen supercompensation,
comprising enlargement of pre-existing glycogen molecules, is a
phenomenon involving a coordinated chain of steps at two levels:
1) Upstream of the glycogen molecule, in association with depleted
Figure 4. Change of glycogenin-1 protein content. Fold change
in glycogenin normalized by total protein content of 1 hour (&) or
24 hours (&) stimulated samples compared to control situation (%)
measured by Western-blot of Glycogenin-1. The inset shows a
representative blot for each situation (from 0 to 24 hours of rest): in
the upper panel samples with 1 hour of CLFS, and the lower panel the
groups with 24 hours of CLFS. C is the contralateral non-stimulated
control sample of each sample showed. In the bar chart the control
group was composed with the pool of all contralateral1 non-stimulated
muscle samples results (n = 50). n = 5 for the stimulated and rested
groups. Data are means 6 SE. There was no statistical difference under
any condition.
doi:10.1371/journal.pone.0042453.g004
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cell energy charge and increased capacity for glucose phos-
phorylation. 2) At the glycogen molecule level, comprising
increased activity of mGS due to the dephosphorylation of site
3a, even at basal glycogen levels, and a stable decrease in the
activity ratio of mGPh during the supercompensation period.
However, early supercompensated glycogen comprises a store
of enlarged poorly branched molecules, which are less efficient
as a GPh substrate.
Figure 5. Total mGS protein and phosphorylation content of the different sites. Fold change of 1 hour (&) or 24 hours (&) stimulated
samples compared to control situation (%) measured by Western-blot of: (A) Total mGS protein content normalized by total protein and
phosphorylation of mGS in (B) site 1a, (C) site 1b, (D) site 2, (E) site 2+2a, (F) site 3a and (G) site 3b, normalized by mGS. The control was composed
with the pool of all contralateral non-stimulated muscle samples results (n = 50). For the stimulated and rested groups n = 5. The upper panels of each
chart contain representative blots to the total mGS or the phosphorylated sites: 1 hour CLFS the upper lane and 24 hours CLFS the lower lane. C: The
correspondent non-stimulated control, and 0 h, 1 h, 6 h, 12 h and 24 h are the time of rest after the stimulation. Data are expressed as box and
whisker plot with the median as a transversal line in the box. Groups with the same letter are not significantly different from each other.
doi:10.1371/journal.pone.0042453.g005
Figure 6. The activation state of AMPK. (A) Representative blots of AMPK-P (T172), AMPKa1 and AMPKa2 isoforms. 1 hour CLFS samples on the
left and 24 hours CLFS on the right. Samples are C: The correspondent non-stimulated control, and 0 h, 1 h, 6 h, 12 h and 24 h are the time of rest
after the stimulation. (B) Quantification of the AMPK-P (T172) Western-blot blot normalized by AMPKa1 in fold change (from 0 to 160 fold) compared
to control and in a different scale (C) with a break from 7 to 35 to better display the data in the control samples and samples rested from 6 to
24 hours. Quantification of AMPKa1 (D) and AMPKa2 (E) in fold change compared to control from the Western-blot normalized by total protein
content. 1 hour (&) and 24 hours (&) stimulated samples n = 5. Control group (%) was composed with the pool of all contralateral non-stimulated
muscle samples results (n = 50). Data are means 6 SE. Bars with the same letter are not significantly different from each other.
doi:10.1371/journal.pone.0042453.g006
Hexokinase and Glycogen Supercompensation
PLoS ONE | www.plosone.org 9 July 2012 | Volume 7 | Issue 7 | e42453
Acknowledgments
We are grateful to Mr. Robin Rycroft for his editorial support. The Serveis
Cientifico-Tecnics, Barcelona, Spain is acknowledged by the HPLC
technique. We are also grateful to Dr. P.J. Roach and Dr. A. DePaoli-
Roach for the helpful critics and by the kind donation of antibodies to
glycogenin and Dr. D.G. Hardie for the antibodies to the different
phosphorylated sites of mGS and AMPK subunits a1 and a2.
Author Contributions
Conceived and designed the experiments: JMI JR JNN JFPW RC.
Performed the experiments: JMI JR MG. Analyzed the data: JMI JR RC.
Contributed reagents/materials/analysis tools: JNN JFPW. Wrote the
paper: JMI RC.
References
1. Roach PJ (2002) Glycogen and its metabolism. Curr Mol Med 2: 101–120.
2. Skurat AV, Dietrich AD, Roach PJ (2000) Glycogen synthase sensivity to insulin
and glucose-6-phosphate is mediated by both NH2- and COOH-terminal
phosphorylation sites. Diabetes 49: 1096–1100.
3. Rose AJ, Richter EA (2005) Skeletal muscle glucose uptake during exercise: How
is it regulated? Physiology 20: 206–270.
4. Fueger PT (2005) Glucose phosphorylation as a barrier to muscle glucose
uptake. Clin Exp Pharmacol Physiol 32: 314–318.
5. Wasserman DH, Kang L, Ayala JE, Fueger PT, Lee-Young RS (2011) The
physiological regulation of glucose flux into muscle in vivo. J Exp Biol 214: 254–
262.
6. Printz R, Koch S, Potter LR, O’Doherty RM, Tiesinga JJ, et al. (1993)
Hexokinase II mRNA and gene structure, regulation by insulin, and evolution.
J Biol Chem 268: 5209–5219.
7. McBride A, Hardie DG (2009) AMP-activated protein kinase–a sensor of
glycogen as well as AMP and ATP? Acta Physiol (Oxf) 196: 99–113.
8. Putman CT, Martins KJ, Gallo ME, Lopaschuk GD, Pearcey JA, et al. (2007)
Alpha-catalytic subunits of 59AMP-activated protein kinase display fiber-specific
expression and are upregulated by chronic low-frequency stimulation in rat
muscle. Am J Physiol Regul Integr Comp Physiol 293: R1325–R1334.
9. Hardie DG (2011) Sensing of energy and nutrients by AMP-activated protein
kinase. Am J Clin Nutr 93: 891S–896S.
10. Hawley JA, Schabort EJ, Noakes TD, Dennis SC (1997) Carbohydrate-loading
and exercise performance. An update. Sports Med 24: 73–81.
11. Bergstrom J, Hultman E (1966) Muscle glycogen synthesis after exercise: An
enhancing factor localised to the muscle cells in humans. Nature 210: 309–310.
12. Calder PC, Geddes R (1992) Heterogeneity of glycogen synthesis upon refeeding
following starvation. Int J Biochem 24: 71–77.
13. Sandstro¨m ME, Abbate F, Andersson DC, Zhang SJ, Westerblad H, et al. (2004)
Insulin-independent glycogen supercompensation in isolated mouse skeletal
muscle: role of phosphorylase inactivation. Pflugers Arch 448: 533–538.
14. Mamedova LK, Shneyvays V, Katz A, Schainberg A (2003) Mechanism of
glycogen supercompensation in rat skeletal muscle cultures. Mol Cell Biochem
250: 11–19.
15. Greiwe JS, Hickner RC, Hansen PA, Racette SB, Chen MM, et al. (1999)
Effects of endurance exercise training on muscle glycogen accumulation in
humans. J Appl Physiol 87: 222–226.
16. Shearer J, Wilson RJ, Battram DS, Richter EA, Robinson DL, et al. (2005)
Increases in Glycogenin and glycogenin mRNA accompany glycogen resynthesis
in human skeletal muscle. Am J Physiol Endocrinol Metab 289: E508–E514.
17. Prats C, Bernal C, Cadefau JA, Frı´as JA, Tibolla M, et al. (2002) Glycogen
depletion and resysnthesis during 14 days of chronic low-frequency stimulation
of rabbit muscle. Biochim Biophys Acta 1573: 68–74.
18. Tan AWH (1979) A simplified method for the preparation of pure
UDP(14C)Glucose. Biochim Biophys Acta 582: 543–547.
19. Pette D, Ramirez BU, Muller W, Simon R, Exner GU, et al. (1975) Influence of
intermittent long-term stimulation on contractile, histochemical and metabolic
properties of fibre populations in fast and slow rabbit muscles. Pflugers Arch 361:
1–7.
20. Suzuki Y, Lanner C, Kim JH, Vilardo PG, Zhang H, et al. (2001) Insulin control
of glycogen metabolism in knockout mice lacking the muscle-specifict protein
phosphatase PP1G/RGL. Mol Cell Biol 21: 2683–2694.
21. Krisman CR (1962) A method for the colorimetrc estimation of glycogen with
Iodine. Anal Biochem 4: 17–23.
22. Cadefau JA, Parra J, Tauler A, Cusso´ R (1999) Contractile activity modifies Fru-
2,6-bP metabolism in rabbit fast twitch skeletal muscle. J Biol Chem 274: 31964–
31966.
23. Lowry OH, Passonneau JV (1972) A flexible system of enzymatic analysis.
24. Tullson PC, Whitlock DM, Terjung RL (1990) Adenine nucleotide degradation
in slow-twitch red muscle. Am J Physiol , Cell Physiol 258: C258–C265.
25. Guinovart JJ, Salavert A, Massague´ J, Ciudad CJ, Salsas E, et al. (1979)
Glycogen synthase: a new activity ratio assay expressing a high sensitivity to the
phosphorylation state. FEBS Lett 106: 284–288.
26. Gilboe DP, Larson KL, Nutall FQ (1972) Radioactive method for the assay of
glycogen phosphorylases. Anal Biochem 47: 20–27.
27. Tagliabracci VS, Girard JM, Segvich D, Meyer C, Turnbull J, et al. (2008)
Abnormal metabolism of glycogen phosphate as a cause for Lafora disease. J Biol
Chem 283: 33816–33825.
28. Davidson AL, Arion WJ (1987) Factors underlying significant underestimations
of glucokinase activity in crude liver extracts: physiological implications of higher
cellular activity. Arch Biochem Biophys 253: 156–167.
29. Cao Y, Steinrauf K, Roach PJ (1995) Mechanism of glycogenin self-
glucosilation. Arch Biochem Biophys 19: 293–298.
30. Bruno C, Servidei S, Shanske S, Karpati G, Carpenter S, et al. (1993) Glycogen
branching enzyme deficiency in adult polyglucosan body disease. Ann Neurol
33: 88–93.
31. Bradford MM (1976) A rapid and sensitive method for the quantitation of
microgram quantities of protein utilizing the principle of protein-dye binding.
Anal Biochem 72: 248–254.
32. Højlund K, Stæhr P, Hansen BF, Green KA, Hardie DG, et al. (2003) Increased
phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites
during physiological hyperinsulinemia in type 2 diabetes. Diabetes 52: 1393–
1402.
33. Pfaffl MW (2001) A new mathematical model for relative quantification in real-
time RT-PCR. Nucleic Acids Res 29: 2002–2007.
34. Laurent D, Hundal RS, Dresner A, Price TB, Vogel SM, et al. (2000)
Mechanism of muscle glycogen autoregulation in humans. Am J Physiol
Endocrinol Metab 278: E663–E668.
35. Garcia-Roves PM, Han DH, Song Z, Jones TE, Hucker KA, et al. (2003)
Prevention of glycogen supercompensation prolongs the increase in muscle
GLUT4 after exercise. Am J Physiol Endocrinol Metab 285: E729–E736.
36. Cadefau JA, Parra J, Cusso´ R, Heine G, Pette D (1993) Responses of fatigable
and fatigue-resistant fibres of rabbit muscle to low-frecuency stimulation.
Pflugers Arch 424: 529–537.
37. Zorzano A, Palacı´n M, Guma` A (2005) Mechanisms regulating GLUT4 glucose
transporter expression and glucose transport in skeletal muscle. Acta Physiol
Scand 183: 43–58.
38. Pette D, Staron RS (2000) Myosin Isoforms, Muscle fiber types, and transitions.
Microsc Res Tech 50: 500–509.
39. O’Doherty RM, Bracy DP, Osawa H, Wasserman DH, Granner DK (1994) Rat
skeletal muscle hexokinase II mRNA and activity are increased by a single bout
of acute exercise. Am J Physiol 266: E171–E178.
40. Hofmann S, Pette D (1994) Low-frequency stimulation of rat fast-twitch muscle
enhances the expression of hexokinase II and both the translocation and
expresion of glucose transporter 4 (GLUT-4). Eur J Biochem 219: 307–315.
41. Koval JA, DeFronzo RA, O’Doherty RM, Printz R, Ardehali H, et al. (1998)
Regulation of hexokinase II activity and expression in human muscle by
moderate exercise. Am J Physiol Endocrinol Metab 274: E304–E308.
42. Fueger PT, Bracy DP, Malabanan CM, Pencek RR, Wasserman DH (2003)
Distributed control of glucose uptake by working muscles of conscious mice:
roles of transport and phosphorylation. Am J Physiol Endocrinol Metab 286:
E77–E84.
43. Wilson RJ, Gusba J, Robinson DL, Graham TE (2007) Glycogenin protein and
mRNA expression in response to changing glycogen concentration in exercise
and recovery. Am J Physiol Endocrinol Metab 292.: E1815–E1822.
44. Nielsen JN, Derave W, Kristiansen S, Ralston E, Ploug T, et al. (2001) Glycogen
synthase localization and activity in rat skeletal muscle is strongly dependent on
glycogen content. J Physiol 531: 757–769.
45. Nielsen JN, Wojtaszewski JFP (2004) Regulation of glycogen synthase activity
and phosphorylation by exercise. Proc Nutr Soc 63: 233–237.
46. Lai YC, Stuenes JT, Kuo CH, Jensen J (2007) Glycogen content and contraction
regulate glycogen synthase phosphorylation and affinity for UDP-glucose in rat
skeletal muscles. Am J Physiol Endocrinol Metab 293: E1622–E1629.
47. Prats C, Helge JW, Nordby P, Qvortrup K, Ploug T, et al. (2009) Dual
regulation of muscle glycogen synthase during exercise, by activation and
compartmentalization. J Biol Chem 284: 15692–15700.
48. Cid E, Cifuentes D, Baque´ S, Ferrer JC, Guinovart JJ (2005) Determinants of the
nucleocytoplasmatic shuttling of muscle Glycogen Synthase. FEBS J 272: 3197–
3213.
49. Prats C, Cadefau JA, Cusso´ R, Qvortrup K, Nielsen JN, et al. (2005)
Phosphorylation-dependent translocation of Glycogen Synthase to a novel
structure during glycogen resynthesis. J Biol Chem 280: 23165–23172.
50. Baque S, Guinovart JJ, Gomez-Foix AM (1996) Overexpression of muscle
glycogen phosphorylase in cultured human muscle fibers causes increased
glucose consumption and nonoxidative disposal. J Biol Chem 271: 2594–2598.
51. Aschenbach WG, Suzuki Y, Breeden K, Prats C, Hirshman MF, et al. (2001)
The muscle-specific protein phosphatase PP1G/RGL(GM) is essential for
activation of glycogen synthase by exercise. J Biol Chem 276: 39959–39967.
52. Jorgensen SB, Nielsen JN, Birk JB, Olsen GS, Viollet B, et al. (2004) The alpha2-
59AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal
muscle and is responsive to glucose loading. Diabetes 53: 3074–3081.
Hexokinase and Glycogen Supercompensation
PLoS ONE | www.plosone.org 10 July 2012 | Volume 7 | Issue 7 | e42453
53. Wojtaszewski JFP, MacDonald C, Nielsen JN, Hellsten Y, Hardie DG, et al.
(2003) Regulation of 5 AMP-activated protein kinase activity and substrate
utilization in exercising human skeletal muscle. Am J Physiol Endocrinol Metab
284: E813–E822.
54. McBride A, Ghilagaber S, Nikolaev A, Hardie DG (2009) The glycogen-binding
domain on the AMPK beta subunit allows the kinase to act as a glycogen sensor.
Cell Metab 9: 23–34.
55. Mele´ndez R, Mele´ndez-Hevia E, Cascante M (1997) How did glycogen structure
evolve to satisfy the requirement for rapid mobilization og glucose? A problem of
physical constraints in structure building. Journal of Molecular Evolution 45:
446–455.
56. Skein M, Duffield R, Kelly BT, Marino FE (2011) The effects of
carbohydrate intake and muscle glycogen content on self-paced intermit-
tent-sprint exercise despite no knowledge of carbohydrate manipulation.
Eur J Appl Physiol.
57. Hatfield DL, Kraemer WJ, Volek JS, Rubin MR, Grebien B, et al. (2006) The
effects of carbohydrate loading on repetitive jump squat power performance.
J Strength Cond Res 20: 167–171.
Hexokinase and Glycogen Supercompensation
PLoS ONE | www.plosone.org 11 July 2012 | Volume 7 | Issue 7 | e42453
